Adapting the Diabetes Prevention Program lifestyle intervention for delivery in the community: The YMCA model

Diabetes Educator

Volumn 33, Issue 1, 2007, Pages 69-78

  Ackermann, Ronald T ^a,b   Marrero, David G ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; DIABETES MELLITUS; HEALTH CARE ORGANIZATION; HEALTH PROMOTION; HUMAN; LIFESTYLE; PATIENT EDUCATION; REVIEW; UNITED STATES;

CLINICAL TRIALS; DIABETES MELLITUS; HEALTH PROMOTION; HUMANS; LIFE STYLE; PATIENT EDUCATION; SOCIETIES; UNITED STATES;

EID: 33846599673     PISSN: 01457217     EISSN: 15546063     Source Type: Journal    
DOI: 10.1177/0145721706297743     Document Type: Review

References (18)

1. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care. 1998 ; 21: 518-524.
2. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA. 2001 ; 286: 1195-1200.
3. Centers for Disease Control and Prevention, Department of Health and Human Services. Diabetes: disabling, deadly, and on the rise. Available at: http://www.cdc.gov/nccdphp/aag/pdf/aag_ddt2004.pdf. Accessed April 15, 2004.
4. American Diabetes Association. National diabetes fact sheet. Available at: http://www.diabetes.org/diabetes-statistics/national-diabetes-fact-sheet. jsp. Accessed May 2, 2004.
5. Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care. 2003 ; 26: 917-932.
6. Department of Health and Human Services, Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2003. Available at: http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2003.pdf. Accessed May 5, 2004.
7. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998 ; 21: 1414-1431.
8. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002 ; 346: 393-403.
9. Garfield SA, Malozowski S, Chin MH, et al. Considerations for diabetes translational research in real-world settings. Diabetes Care. 2003 ; 26: 2670-2674.
10. Glasgow RE. Translating research to practice: lessons learned, areas for improvement, and future directions. Diabetes Care. 2003 ; 26: 2451-2456.
11. The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care. 2002 ; 25: 2165-2171.
12. Wing RR, Hamman RF, Bray GA, et al. Achieving weight and activity goals among diabetes prevention program lifestyle participants. Obes Res. 2004 ; 12: 1426-1434.
13. Saydah SH, Eberhardt MS, Loria CM, Brancati FL. Age and the burden of death attributable to diabetes in the United States. Am J Epidemiol. 2002 ; 156: 714-719.
14. Jakicic JM, Clark K, Coleman E, et al. American College of Sports Medicine position stand. Appropriate intervention strategies for weight loss and prevention of weight regain for adults. Med Sci Sports Exerc. 2001 ; 33: 2145-2156.
15. National Heart, Lung, and Blood Institute. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Bethesda, Md: National Heart, Lung, and Blood Institute; National Institutes of Health; Public Health Service ; September 1998.
16. Herman WH, Brandle M, Zhang P, et al. Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program. Diabetes Care. 2003 ; 26: 36-47.
17. Ackermann RT, Marrero DG, Hicks K, et al. An evaluation of cost-sharing to finance a diet and physical activity intervention to prevent diabetes. Diabetes Care. 2006 ; 29: 1237-1241.
18. Herman WH, Hoerger TJ, Brandle M, et al. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med. 2005 ; 142: 323-332.